C4 Therapeutics Inc (CCCC)
5.72
-0.08
(-1.38%)
USD |
NASDAQ |
May 23, 12:22
C4 Therapeutics Shareholders Equity (Quarterly): 258.28M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 258.28M |
| December 31, 2023 | 246.11M |
| September 30, 2023 | 216.02M |
| June 30, 2023 | 233.71M |
| March 31, 2023 | 262.47M |
| December 31, 2022 | 289.23M |
| September 30, 2022 | 318.18M |
| June 30, 2022 | 344.59M |
| March 31, 2022 | 364.53M |
| Date | Value |
|---|---|
| December 31, 2021 | 389.61M |
| September 30, 2021 | 398.78M |
| June 30, 2021 | 416.43M |
| March 31, 2021 | 263.70M |
| December 31, 2020 | 280.79M |
| September 30, 2020 | -155.92M |
| June 30, 2020 | 123.78M |
| December 31, 2019 | -111.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-155.92M
Minimum
Sep 2020
416.43M
Maximum
Jun 2021
243.43M
Average
263.70M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Alector Inc | 178.91M |
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 398.37M |
| Total Liabilities (Quarterly) | 140.09M |
| Current Ratio | 5.082 |
| Net Debt Paydown Yield | 0.41% |